Advances in the biology and therapy of chronic myeloid leukemia: Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

Richard A. Van Etten, Michael Mauro, Jerald P. Radich, John M. Goldman, Giuseppe Saglio, Catriona Jamieson, Simona Soverini, Carlo Gambacorti-Passerini, Rüdiger Hehlmann, Giovanni Martinelli, Danilo Perrotti, David T. Scadden, Tomasz Skorski, Ayalew Tefferi, Tariq I. Mughal

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Following the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego in December 2011, a group of clinical and laboratory investigators convened for the 6th Post-ASH International Workshop on Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN). The Workshop took place on 13-14 December at the Estancia, La Jolla, California, USA. This report summarizes the most recent advances in the biology and therapy of CML that were presented at the ASH meeting and discussed at the Workshop. Preclinical studies focused on the CML stem cell and its niche, and on early results of deep sequencing of CML genomes. Clinical advances include updates on second- and third-generation tyrosine kinase inhibitors (TKIs), molecular monitoring, TKI discontinuation studies and new therapeutic agents. A report summarizing the pertinent advances in MPN has been published separately.

Original languageEnglish (US)
Pages (from-to)1151-1158
Number of pages8
JournalLeukemia and Lymphoma
Volume54
Issue number6
DOIs
StatePublished - Jun 2013

Fingerprint

Hematology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Education
Protein-Tyrosine Kinases
Neoplasms
Stem Cell Niche
Myeloid Progenitor Cells
High-Throughput Nucleotide Sequencing
Therapeutics
Research Personnel
Genome

Keywords

  • Chronic myelogenous leukemia
  • Dasatinib
  • Imatinib mesylate
  • Nilotinib
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Advances in the biology and therapy of chronic myeloid leukemia : Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. / Van Etten, Richard A.; Mauro, Michael; Radich, Jerald P.; Goldman, John M.; Saglio, Giuseppe; Jamieson, Catriona; Soverini, Simona; Gambacorti-Passerini, Carlo; Hehlmann, Rüdiger; Martinelli, Giovanni; Perrotti, Danilo; Scadden, David T.; Skorski, Tomasz; Tefferi, Ayalew; Mughal, Tariq I.

In: Leukemia and Lymphoma, Vol. 54, No. 6, 06.2013, p. 1151-1158.

Research output: Contribution to journalArticle

Van Etten, RA, Mauro, M, Radich, JP, Goldman, JM, Saglio, G, Jamieson, C, Soverini, S, Gambacorti-Passerini, C, Hehlmann, R, Martinelli, G, Perrotti, D, Scadden, DT, Skorski, T, Tefferi, A & Mughal, TI 2013, 'Advances in the biology and therapy of chronic myeloid leukemia: Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop', Leukemia and Lymphoma, vol. 54, no. 6, pp. 1151-1158. https://doi.org/10.3109/10428194.2012.745524
Van Etten, Richard A. ; Mauro, Michael ; Radich, Jerald P. ; Goldman, John M. ; Saglio, Giuseppe ; Jamieson, Catriona ; Soverini, Simona ; Gambacorti-Passerini, Carlo ; Hehlmann, Rüdiger ; Martinelli, Giovanni ; Perrotti, Danilo ; Scadden, David T. ; Skorski, Tomasz ; Tefferi, Ayalew ; Mughal, Tariq I. / Advances in the biology and therapy of chronic myeloid leukemia : Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. In: Leukemia and Lymphoma. 2013 ; Vol. 54, No. 6. pp. 1151-1158.
@article{8489c19790f4422483271eca70976531,
title = "Advances in the biology and therapy of chronic myeloid leukemia: Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop",
abstract = "Following the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego in December 2011, a group of clinical and laboratory investigators convened for the 6th Post-ASH International Workshop on Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN). The Workshop took place on 13-14 December at the Estancia, La Jolla, California, USA. This report summarizes the most recent advances in the biology and therapy of CML that were presented at the ASH meeting and discussed at the Workshop. Preclinical studies focused on the CML stem cell and its niche, and on early results of deep sequencing of CML genomes. Clinical advances include updates on second- and third-generation tyrosine kinase inhibitors (TKIs), molecular monitoring, TKI discontinuation studies and new therapeutic agents. A report summarizing the pertinent advances in MPN has been published separately.",
keywords = "Chronic myelogenous leukemia, Dasatinib, Imatinib mesylate, Nilotinib, Tyrosine kinase inhibitor",
author = "{Van Etten}, {Richard A.} and Michael Mauro and Radich, {Jerald P.} and Goldman, {John M.} and Giuseppe Saglio and Catriona Jamieson and Simona Soverini and Carlo Gambacorti-Passerini and R{\"u}diger Hehlmann and Giovanni Martinelli and Danilo Perrotti and Scadden, {David T.} and Tomasz Skorski and Ayalew Tefferi and Mughal, {Tariq I.}",
year = "2013",
month = "6",
doi = "10.3109/10428194.2012.745524",
language = "English (US)",
volume = "54",
pages = "1151--1158",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Advances in the biology and therapy of chronic myeloid leukemia

T2 - Proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

AU - Van Etten, Richard A.

AU - Mauro, Michael

AU - Radich, Jerald P.

AU - Goldman, John M.

AU - Saglio, Giuseppe

AU - Jamieson, Catriona

AU - Soverini, Simona

AU - Gambacorti-Passerini, Carlo

AU - Hehlmann, Rüdiger

AU - Martinelli, Giovanni

AU - Perrotti, Danilo

AU - Scadden, David T.

AU - Skorski, Tomasz

AU - Tefferi, Ayalew

AU - Mughal, Tariq I.

PY - 2013/6

Y1 - 2013/6

N2 - Following the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego in December 2011, a group of clinical and laboratory investigators convened for the 6th Post-ASH International Workshop on Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN). The Workshop took place on 13-14 December at the Estancia, La Jolla, California, USA. This report summarizes the most recent advances in the biology and therapy of CML that were presented at the ASH meeting and discussed at the Workshop. Preclinical studies focused on the CML stem cell and its niche, and on early results of deep sequencing of CML genomes. Clinical advances include updates on second- and third-generation tyrosine kinase inhibitors (TKIs), molecular monitoring, TKI discontinuation studies and new therapeutic agents. A report summarizing the pertinent advances in MPN has been published separately.

AB - Following the 53rd annual meeting of the American Society of Hematology (ASH) in San Diego in December 2011, a group of clinical and laboratory investigators convened for the 6th Post-ASH International Workshop on Chronic Myeloid Leukemia (CML) and Myeloproliferative Neoplasms (MPN). The Workshop took place on 13-14 December at the Estancia, La Jolla, California, USA. This report summarizes the most recent advances in the biology and therapy of CML that were presented at the ASH meeting and discussed at the Workshop. Preclinical studies focused on the CML stem cell and its niche, and on early results of deep sequencing of CML genomes. Clinical advances include updates on second- and third-generation tyrosine kinase inhibitors (TKIs), molecular monitoring, TKI discontinuation studies and new therapeutic agents. A report summarizing the pertinent advances in MPN has been published separately.

KW - Chronic myelogenous leukemia

KW - Dasatinib

KW - Imatinib mesylate

KW - Nilotinib

KW - Tyrosine kinase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84877787719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877787719&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.745524

DO - 10.3109/10428194.2012.745524

M3 - Article

C2 - 23121619

AN - SCOPUS:84877787719

VL - 54

SP - 1151

EP - 1158

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 6

ER -